BBIO
Bridgebio Pharma Inc
$26.02
Earnings Summary
Revenue | $2.17Mn |
Net Profits | $-73.46Mn |
Net Profit Margins | -3388.19% |
Highlights
Bridgebio Pharma Inc’s revenue jumped 32.11% since last year same period to $2.17Mn in the Q2 2024. On a quarterly growth basis, Bridgebio Pharma Inc has generated -98.97% fall in its revenue since last 3-months.
Bridgebio Pharma Inc’s net profit jumped 53.48% since last year same period to $-73.46Mn in the Q2 2024. On a quarterly growth basis, Bridgebio Pharma Inc has generated -108.59% fall in its net profits since last 3-months.
Bridgebio Pharma Inc’s net profit margin jumped 64.79% since last year same period to -3388.19% in the Q2 2024. On a quarterly growth basis, Bridgebio Pharma Inc has generated -20212.22% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Bridgebio Pharma Inc post its latest quarter earnings
EPS Estimate Current Year | -0.89 |
Highlights
Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current year stand at -0.89.
Key Ratios
Key ratios of the Bridgebio Pharma Inc post its Q2 2024 earnings
Earning Per Share (EPS) | -0.39 |
Highlights
Bridgebio Pharma Inc’s earning per share (EPS) jumped 60.2% since last year same period to -0.39 in the Q2 2024. This indicates that the Bridgebio Pharma Inc has generated 60.2% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-01 | -1.06 | -0.39 | 63.21% |
2024-05-02 | -0.71 | -0.2 | 71.83% |
₹0 US Stocks a/c Opening Fee